Daily pill trial aims to shrink dangerous blood vessel tangles
NCT ID NCT07037238
Summary
This small study is testing whether a daily pill called everolimus can safely shrink abnormal blood vessel growths (vascular malformations) in adults. Ten participants who aren't good candidates for surgery will take the medication and have regular MRI scans to see if their lesions get smaller. The goal is to control the growth and reduce bleeding risks from these malformations.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASCULAR MALFORMATIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
the Department of Neurosurgery, China International Neuroscience Institute, Xuanwu Hospital, Capital Medical University
RECRUITINGBeijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.